Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Cochlear ( (AU:COH) ).
Cochlear Limited has announced the issuance of 42,880 unquoted equity securities, which were converted from options or other convertible securities. This move could potentially impact the company’s financial structure and market positioning by increasing the number of shares in circulation, which may influence shareholder value and investment appeal.
The most recent analyst rating on (AU:COH) stock is a Buy with a A$333.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical devices industry, specializing in implantable hearing solutions. The company is known for its cochlear implants and other hearing-related products, focusing on improving the quality of life for individuals with hearing loss.
Average Trading Volume: 140,057
Technical Sentiment Signal: Buy
Current Market Cap: A$18.76B
See more insights into COH stock on TipRanks’ Stock Analysis page.